Thymosin Alpha 1 10mg
Retatrutide is a cutting-edge tri-agonist peptide that is transforming the field of metabolic research. Designed to simultaneously activate the GLP-1, GIP, and GCGR (glucagon) receptors, this multifunctional peptide offers a more comprehensive and synergistic approach to modulating appetite, enhancing insulin function, and accelerating fat metabolism.
⚠️ Important Disclaimer
For Research Use Only. Not for human consumption or therapeutic treatment.
Retatrutide
KEY BENEFITS
Lose Up to 24 % of Your Body Weight
Phase-2 data show retatrutide users shed an average 24 % of starting weight in just 48 weeks—roughly a quarter of their scale number gone.
Triple-Hormone Power = Faster Fat Burn
By activating GLP-1, GIP and glucagon receptors in one molecule, retatrutide cuts hunger while raising energy expenditure, attacking fat from both sides.
Steady Blood-Sugar & Insulin Control
Trials report sharp drops in HbA1c, fasting glucose and insulin resistance, helping you stay in the healthy zone between meals.
Targets Visceral & Liver Fat
Participants saw visceral-fat shrinkage, liver-fat normalization and >40 % falls in triglycerides—key for metabolic and liver health.
Heart-Smart Cardiometabolic Tune-Up
Expect slimmer waists plus meaningful reductions in systolic/diastolic blood pressure and LDL, polishing your overall risk profile.
Once-Weekly Micro-Dose Convenience
A tiny 0.1 mL sub-Q shot once a week keeps levels steady—no daily pills, no mid-day reminders.
Gentle, Short-Lived Side-Effect Profile
Most users report only mild, transient GI upset typical of GLP-1 treatments, with symptoms easing as dosing stabilizes.
Rigorous Quality Testing
Each vial of Retatrutide undergoes stringent quality control measures to meet the highest research standards. It is lab-tested for purity, potency, and consistency, with a certificate of analysis (COA) provided for every batch. With a purity exceeding 99%, this lyophilized peptide powder is ideal for controlled research environments that demand reliable and repeatable results.
Why Choose Retatrutide?
Retatrutide is a cutting-edge tri-agonist peptide that is transforming the field of metabolic research. Designed to simultaneously activate the GLP-1, GIP, and GCGR (glucagon) receptors, this multifunctional peptide offers a more comprehensive and synergistic approach to modulating appetite, enhancing insulin function, and accelerating fat metabolism.
What Sets Retatrutide Apart
What sets Retatrutide apart from traditional single-pathway compounds like semaglutide is its ability to address multiple metabolic pathways at once, making it highly attractive for advanced obesity, diabetes, and longevity studies.
Studies
INSERT STUDY
INSERT STUDY
INSERT STUDY
INSERT STUDY
INSERT STUDY
INSERT STUDY
Retatrutide FAQs
What is Retatrutide?
Retatrutide is a research-grade peptide known for its tri-agonist activity—activating GLP-1, GIP, and glucagon receptors simultaneously. It is being studied in scientific settings for its unique mechanism of action across metabolic pathways.
Is Retatrutide a natural peptide?
No. Retatrutide is a synthetic peptide, engineered in laboratory settings to mimic and enhance the function of naturally occurring hormonal pathways in research models.
What is Retatrutide used for in research?
Retatrutide is commonly studied in metabolic, obesity, glucose regulation, and energy balance models. Its triple-receptor profile makes it an ideal candidate for preclinical exploration of multi-receptor metabolic interactions.
What is the recommended Retatrutide dosage in research?
Research protocols often begin with 0.25mg and may scale to 0.5mg or 1mg, depending on the experimental model and study goals. Dosage should be determined based on internal SOPs and protocol requirements.
Is there a Retatrutide dosage chart available?
Yes. Dosage charts for Retatrutide are typically created based on model weight, study length, and receptor activation goals. Charts often show titration schedules from 0.25mg up to 1mg over several weeks.
Can Retatrutide be combined with other peptides in research?
Yes. Retatrutide is frequently used in research stacks with peptides such as Tesamorelin, CJC-1295, or Cagrilintide to explore synergistic effects in metabolic modeling.
Is Retatrutide a GLP-1 agonist only?
No. Retatrutide is classified as a triple agonist, meaning it activates GLP-1, GIP, and GCGR receptors, offering a broader biological profile for researchers studying complex peptide interactions.
How is Retatrutide stored for lab use?
Lyophilized Retatrutide should be stored at or below -20°C for long-term stability. After reconstitution, storage in a refrigerated environment is generally recommended as per research protocols.
Is Retatrutide approved for human or therapeutic use?
No. Retatrutide is not approved by the FDA and is sold strictly for laboratory and research purposes only. It is not intended for human or veterinary use.
Where is your Retatrutide peptide manufactured?
Our Retatrutide is USA-manufactured under cGMP-like conditions, with each batch lab-tested for purity, potency, and consistency. Certificates of Analysis (COA) are provided for all research peptides.